Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.710
-0.150 (-8.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.661
-0.049 (-2.89%)
After-hours: Dec 5, 2025, 7:31 PM EST
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $47.85 million as of December 5, 2025. Its market cap has decreased by -84.58% in one year.
Market Cap
47.85M
Enterprise Value
-1.34M
1-Year Change
-84.58%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $47.85M, a decrease of -61.02%. That is a compound annual growth rate of -14.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 47.85M | -85.08% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |